BiotechTube

Atezolizumab Injection [Tecentriq]

ApprovedCompleted
0 views this week 0 watching⚡ Active
Interest: 43/100
43
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Lung Neoplasm Malignant

Conditions

Lung Neoplasm Malignant

Trial Timeline

Dec 18, 2019 → Jun 30, 2022

NCT ID
NCT04059887

About Atezolizumab Injection [Tecentriq]

Atezolizumab Injection [Tecentriq] is a approved stage product being developed by Roche for Lung Neoplasm Malignant. The current trial status is completed. This product is registered under clinical trial identifier NCT04059887. Target conditions include Lung Neoplasm Malignant.

What happened to similar drugs?

20 of 20 similar drugs in Lung Neoplasm Malignant were approved

Approved (20) Terminated (3) Active (0)
✅Sivelestat sodium hydrate + Sivelestat sodium hydrateOno PharmaceuticalApproved
✅Pemetrexed + CarboplatinEli LillyApproved
✅pemetrexedEli LillyApproved
✅Budesonide + SymbicortAstraZenecaApproved
✅Symbicort® total dose 400ug/12ug + Symbicort® total dose 800ug/24ug + Formoterol 24ug + BUD total dose 800ugAstraZenecaApproved
✅Osimertinib+cisplatin or carboplatin + pemetrexed EditAstraZenecaApproved
✅DurvalumabAstraZenecaApproved

Hype Score Breakdown

Clinical
20
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (2)

NCT IDPhaseStatus
NCT04059887ApprovedCompleted
NCT04186013Phase 2Active

Competing Products

20 competing products in Lung Neoplasm Malignant

See all competitors
ProductCompanyStageHype Score
BBP-398 with nivolumabBridgeBio PharmaPhase 1
18
Pemetrexed + CarboplatinEli LillyPhase 3
40
Necitumumab + Gemcitabine + CarboplatinEli LillyPhase 2
27
SelpercatinibEli LillyPre-clinical
26
Pemetrexed + Cisplatin + Placebo + PemetrexedEli LillyPhase 3
40
NBTXR3NanobiotixPhase 1/2
33
PemetrexedEli LillyPre-clinical
26
pemetrexed + erlotinibEli LillyPhase 2
35
Necitumumab-Gemcitabine-CisplatinEli LillyPhase 2
27
LY3295668 ErbumineEli LillyPhase 1
29
FYB206 + FYB206 + KeytrudaFormycon AGPhase 3
22
6-Thio-2'-Deoxyguanosine + CemiplimabMAIA BiotechnologyPhase 2
32
6-Thio-2'-Deoxyguanosine + Cemiplimab + Docetaxel + Vinorelbine + Gemcitabine aloneMAIA BiotechnologyPhase 3
37
pemetrexed + cisplatinEli LillyPhase 2
27
gemcitabine + carboplatin + cisplatinEli LillyPhase 2
35
CetuximabEli LillyPhase 1
29
pemetrexed + docetaxelEli LillyPhase 3
40
enzastaurin + pemetrexed + docetaxel + carboplatinEli LillyPhase 2
35
PemCarbo + Pem onlyEli LillyPhase 3
36
TNG456 + abemaciclibEli LillyPhase 1/2
39